Telemedicine and Hemophilia in the Age of COVID-19

Role of telemedicine during the COVID-19 pandemic analysed in Haemophilia

A commentary, published in the World Federation of Hemophilia’s journal Haemophilia by NHF President and CEO Leonard A. Valentino, MD, NHF Medical and Scientific Advisory Council chair Steve Pipe, MD, and Mark Skinner, JD looks at how telemedicine has impacted the process of maintaining access to hemophilia treatment products and to specialized integrated care in HTCs.

A new letter to the editor, published in Haemophilia, the official journal of the World Federation of Hemophilia (WFH), looks at how healthcare practitioners are using telemedicine to support the bleeding disorders community. The role of telemedicine in the delivery of healthcare in the COVID‐19 Pandemic was written by Leonard. A. Valentino, Mark W. Skinner and Steven Pipe. The letter looks at how telemedicine has impacted the process of maintaining access to hemophilia treatment products and to specialized integrated care medical in hemophilia treatment centers (HTCs). Read the article here.